NKTR - Nektar Therapeutics GAAP EPS of -$0.73 misses by $0.47 revenue of $21.6M beats by $2.17M
2023-05-09 16:18:14 ET
- Nektar Therapeutics press release ( NKTR ): Q1 GAAP EPS of -$0.73 misses by $0.47 .
- Revenue of $21.6M (-12.9% Y/Y) beats by $2.17M .
- Shares -1.9% .
-
- Cash and investments in marketable securities at March 31, 2023, were $456.8 million as compared to $505.0 million at December 31, 2022.
For further details see:
Nektar Therapeutics GAAP EPS of -$0.73 misses by $0.47, revenue of $21.6M beats by $2.17M